Committed to disrupting how health is discovered, developed and delivered, in a citizen/patient centric way, through big data generation, mining and AI, new business models, and holistic, interdisciplinary approaches.
Director of Computational Biology at Boehringer Ingelheim Pharma since July 2014, after having developed experience in academic and clinical environments in both genomics and computational biology. Experienced in leading large collaborative interdisciplinary projects across basic, translational and clinical research.
Specialties: patient-centric research, computational biology, genomics, biomedical knowledge management